LIFE SCIENCES · REGULATED SCALE-UPS

Strategic finance for venture-backed companies. From decision to delivery.

We work with life-science and other regulated companies on funding, first launch, European expansion and AI in the finance function. Every engagement ends with something your team can use: a model, a plan or a working process.

Start a conversation See what we do
  • Written scope before work begins
  • Defined deliverables
  • A small senior team
  • Interests disclosed in writing

01 / OUR METHOD

A recommendation is not a result.

  1. 01

    Frame

    We agree the decision, the evidence it needs and the deliverables in a written scope.

  2. 02

    Build

    We build the model, plan or process with your team and your data, and write the assumptions down.

  3. 03

    Implement

    We put it to work with you: in the board paper, the reporting, the close or the pilot.

  4. 04

    Hand over

    Everything is documented and left with your team, so it runs without us.

02 / WHEN TO CALL

You should call us when…

For founders & CEOs

  • Your next round is 6–12 months out and the model, data room and equity story are not yet investor-grade.
  • You are preparing a first European launch and need pricing, access and working-capital plans that hold up.
  • You are opening entities across Europe and the close, intercompany and controls are falling behind.
  • Your finance team loses its month to close and reporting, and you want to automate with the controls in place.

For investors & boards

  • A portfolio company needs interim finance leadership, quickly.
  • You want an independent finance read before investing: burn, runway, launch assumptions, structure.
  • A board wants an independent view on a financing, launch or expansion plan.
  • You need to judge whether a company’s “AI-enabled operations” claim is real.

03 / WHAT WE DO

Four areas. One way of working.

The moments where finance decides what a venture-backed company can do next.

01 / 04

Funding & investor readiness

An equity story the numbers can carry.

Financial model, data room, investor narrative, diligence preparation and round mechanics.

How we engage
02 / 04

Launch & commercial finance

Make launch assumptions explicit.

Launch P&L, pricing and access economics, gross-to-net, distributor models and working capital across Europe.

How we engage
03 / 04

Switzerland & EMEA build-out

From one entity to many, in control.

Finance structure for a Swiss hub and European entities: intercompany, consolidation, close and reporting.

More on athossp.ch
04 / 04

AI for finance

Systems prepare. People approve.

Diagnostics and controlled pilots for close, consolidation and board reporting.

More on athossp.ai

04 / WHERE WE FOCUS

Life sciences first. Regulated scale-ups alongside.

We work where long development timelines, regulated markets and investor scrutiny make finance decisions unusually consequential.

01 / THERAPEUTICS

Rare disease & specialty pharma

Small populations, high prices, complex access — where finance decides the launch.

02 / ADVANCED THERAPIES

Cell & gene therapy

One-time treatments, novel payment models and demanding manufacturing economics.

03 / BEYOND LIFE SCIENCES

Regulated, venture-backed scale-ups

Audited, investor-funded companies that need institutional-quality numbers early.

05 / ENGAGEMENTS

Three ways to work together.

Every engagement starts with a written scope: deliverables, responsibilities and timetable, agreed before work begins.

Discuss a scope
01

Decision sprint

One decision · defined deliverables

For a funding, launch or expansion decision that needs evidence and a recommendation.

You receive Scenario model · assumptions register · written recommendation

02

Embedded finance leadership

Fractional or interim CFO · ongoing

We run finance with your team until a full-time CFO is justified, then help you hire one.

You receive Runway and budget · board reporting · finance team and systems

03

Board & investor advisory

Periodic · as needed

An independent finance view for boards and investors, before a decision is taken.

You receive Finance review notes · portfolio reviews · CFO hiring support

06 / WHO DOES THE WORK

A small senior team. One lead throughout.

Every engagement is staffed by a small senior team. One lead stays with it from the first conversation to the handover, and you meet the people who will do the work before any scope is signed.

Alongside your advisers
Where a scope needs legal, tax, regulatory or technical depth, we work with your advisers or bring in independent specialists.
Independent
Before work begins, we disclose in writing any commercial interest we hold in a tool, vendor or company relevant to your engagement.

ONE FIRM · THREE SITES

athossp.comThe firmAll services: funding, launch, expansion and AI in finance.athossp.chSwitzerland & EMEAThe finance side of building in and from Switzerland.athossp.aiAI for financeFinance-led AI pilots, with controls at every step.

07 / BEGIN A CONVERSATION

What is your company about to do?

Tell us the company, the decision ahead and your timing.

  1. Send a short email — it opens with four questions to answer.
  2. We reply to arrange a 30-minute call with the people who would lead the work.
  3. If there is a fit, you receive a written scope before any work begins.
contact@athossp.com